Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 55 News Items found In the Clinic FDA Approves New Drug for Non-Small Cell Lung Cancer With ROS1 Fusions Wednesday, January 10, 2024 Learn more about the new FDA-approved drug repotrectinib (AugtyroTM), which targets ROS1 fusions in lung cancer and other cancer types. FDA Grants Accelerated Approval to Repotrectinib for Cancers with NTRK Fusions Thursday, June 13, 2024 The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators. Ask the Expert Should I Drink Coffee to Prevent Colorectal Cancer? Friday, March 22, 2019 Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions. Q&A Answers to Common Questions about Radiation Safety Thursday, May 28, 2020 MSK radiation therapy experts set the record straight about the safety of this effective treatment. How to Keep Holiday Traditions and Culture while Cooking for People with Cancer Monday, November 22, 2021 Learn how to make guests with cancer feel welcome and included at the table this holiday season. Support 8 Tips for Managing Weight during and after Cancer Treatment Friday, June 26, 2015 Learn how to eat right and stay at a healthy weight by following these tips from MSK experts on diet and nutrition. A Major Advance: Tracking and Treating Hidden Prostate Cancer Cells Thursday, July 1, 2021 A new technology shows great promise for imaging and treating advanced forms of prostate cancer. A Promising New Therapy for Advanced Prostate Cancer Thursday, June 3, 2021 A new treatment that selectively seeks out prostate cancer cells shows great promise for treating advanced forms of the disease. Feature 5 Surprising Facts about Melanoma Tuesday, May 11, 2021 Expand your knowledge of melanoma with these surprising facts. FDA Approves New Treatment for Triple-Negative Breast Cancer Tuesday, June 23, 2026 The FDA has approved the targeted therapy datopotamab deruxtecan (Datroway® or Dato-DXd) for triple-negative breast cancer based on clinical research led by MSK. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment